Lutetium-177 vipivotide tetraxetan
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- December 2023
Comments
DNP: NICE TA930 Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatments- Not recommended (Decision - December 2023)search again
